Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

New Rhein Healthcare Investors

Status
ACTIVE
Global HQ
Philadelphia, United States
Countries of investment
  • USA
  • Germany
Investment stages
  • Seed
  • Series B
Industries
  • Health Tech
  • Fintech
  • AI
  • Internet
About
New Rhein Healthcare Investors is a healthcare venture capital firm specializing in repurposed assets, investing in companies to help them attract strategic investors. Focus areas include specialty Rx, biologics, vaccines, and emerging markets.
Min check size
-
Max check size
-
Fund size
NPS

Investment Thesis

New Rhein Healthcare Investors focuses on investing in early and growth stage healthcare companies with transformative solutions and strong market potential.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in the private equity landscape, the fund manager has executed numerous investments primarily in the technology and healthcare sectors across North America and Europe. They have led over 30 deals, focusing on growth and buyout stages, and have achieved notable exits that underscore their data-driven investment strategy. Their approach emphasizes a thematic focus on innovation, enabling them to identify and leverage emerging trends effectively. This operator-first mindset allows for enhanced value creation and long-term success within their portfolio companies.

New Rhein Healthcare Investors Contacts Information

Primary contact

Secondary contact

Team

Ivan Gergel

Greg Parekh

Greg Parekh

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp